b2venture

b2venture (formerly btov Partners) is one of the longer-running European seed and Series A venture firms, with offices in Berlin, Munich, and Zurich, and a real healthcare investment track record. The firm invests at seed and Series A with checks of $1M-$10M, and has a notable life sciences and digital health portfolio. Best fit: European, especially German-speaking-region founders building digital health, AI-enabled healthcare, healthcare software, life sciences tools, or medical devices at seed or Series A, who would benefit from a thoughtful European lead with a long history of company building; founders looking for a partner that can lead a European round and bridge to US follow-on capital. Entry path is the b2venture website (which has clear partner profiles by sector) and warm intros through the firm’s portfolio and the broader DACH-region tech and life sciences ecosystem. Not a fit for US-only founders, biotech therapeutics, or consumer wellness brands without a real European market thesis. For a European healthcare or life sciences founder at seed or Series A, this is one of the more credible regional doors; for non-European founders, the firm’s geographic focus makes this a lower-priority target.